NKTR · NASDAQ · Biotechnology

Nektar Therapeutics (NKTR)

Develops investigational immune-modulating medicines for autoimmune disease and cancer.

$61.45
After hours+0.51 (+0.84%)
At close$60.94(−8.83%)